Universite Catholique de Louvain

As companies pursue many different targets and modalities in search of the first and best therapy to treat the broad unmet medical need in non-alcoholic steatohepatitis (NASH), Promethera Bioscience

IN VITRO DIAGNOSTICS Mergers & Acquisitions Cooper Cos. Inc. CooperSurgical Inc. Genesis Genetics Cooper Cos. Inc. 's women's health division CooperSurgical Inc. acquired private genetic testin

Financings During the third quarter of 2015, start-up companies raised a total of $2.57 billion, $39 million less than last quarter. Biopharma companies pulled in an impressive $2.38 billion, 53% resu

IN VITRO DIAGNOSTICS Ativa Medical Corp. Ativa Medical closes $23mm Series B round to support micro lab development Diagnostics firm Ativa Medical Corp. raised $23mm through its Series B round